Clinical Trial Update: Impact of Intravenous Methylprednisolone Treatment on Blood Pressure

View source ↗

Summary

The clinical trial evaluating intravenous methylprednisolone's impact on blood pressure in Graves disease and Graves ophthalmopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease
• Graves Ophthalmopathy

Drugs mentioned

• SOLU-MEDROL (Methylprednisolone sodium succinate)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Graves Disease, Graves Ophthalmopathy | Status: COMPLETED